Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

A new pathway to eSCAPe lipotoxicity.

Benhamed F, Postic C.

Clin Res Hepatol Gastroenterol. 2018 Feb;42(1):3-5. doi: 10.1016/j.clinre.2017.10.005. Epub 2017 Nov 22.

PMID:
29174379
2.

Liver Reptin/RUVBL2 controls glucose and lipid metabolism with opposite actions on mTORC1 and mTORC2 signalling.

Javary J, Allain-Courtois N, Saucisse N, Costet P, Heraud C, Benhamed F, Pierre R, Bure C, Pallares-Lupon N, Do Cruzeiro M, Postic C, Cota D, Dubus P, Rosenbaum J, Benhamouche-Trouillet S.

Gut. 2017 Oct 26. pii: gutjnl-2017-314208. doi: 10.1136/gutjnl-2017-314208. [Epub ahead of print]

PMID:
29074727
3.

A Specific ChREBP and PPARα Cross-Talk Is Required for the Glucose-Mediated FGF21 Response.

Iroz A, Montagner A, Benhamed F, Levavasseur F, Polizzi A, Anthony E, Régnier M, Fouché E, Lukowicz C, Cauzac M, Tournier E, Do-Cruzeiro M, Daujat-Chavanieu M, Gerbal-Chalouin S, Fauveau V, Marmier S, Burnol AF, Guilmeau S, Lippi Y, Girard J, Wahli W, Dentin R, Guillou H, Postic C.

Cell Rep. 2017 Oct 10;21(2):403-416. doi: 10.1016/j.celrep.2017.09.065.

4.

Dietary oleic acid regulates hepatic lipogenesis through a liver X receptor-dependent signaling.

Ducheix S, Montagner A, Polizzi A, Lasserre F, Régnier M, Marmugi A, Benhamed F, Bertrand-Michel J, Mselli-Lakhal L, Loiseau N, Martin PG, Lobaccaro JM, Ferrier L, Postic C, Guillou H.

PLoS One. 2017 Jul 21;12(7):e0181393. doi: 10.1371/journal.pone.0181393. eCollection 2017.

5.

[Clinical and etiological profile malignant hypertension in children in pediatric intensive care].

Batouche DD, Kerboua KE, Sadaoui L, Benhamed F, Zohret-Bouhalouane S, Boucherit N, Berexi-Reguig M, Elhalimi K, Benatta NF.

Ann Cardiol Angeiol (Paris). 2016 Jun;65(3):165-70. doi: 10.1016/j.ancard.2016.04.006. Epub 2016 May 12. French.

PMID:
27180561
6.

Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD.

Montagner A, Polizzi A, Fouché E, Ducheix S, Lippi Y, Lasserre F, Barquissau V, Régnier M, Lukowicz C, Benhamed F, Iroz A, Bertrand-Michel J, Al Saati T, Cano P, Mselli-Lakhal L, Mithieux G, Rajas F, Lagarrigue S, Pineau T, Loiseau N, Postic C, Langin D, Wahli W, Guillou H.

Gut. 2016 Jul;65(7):1202-14. doi: 10.1136/gutjnl-2015-310798. Epub 2016 Feb 1.

7.

O-GlcNAcylation Links ChREBP and FXR to Glucose-Sensing.

Benhamed F, Filhoulaud G, Caron S, Lefebvre P, Staels B, Postic C.

Front Endocrinol (Lausanne). 2015 Jan 13;5:230. doi: 10.3389/fendo.2014.00230. eCollection 2014. Review.

8.

Insulin-induced cell division is controlled by the adaptor Grb14 in a Chfr-dependent manner.

Perdereau D, Cailliau K, Browaeys-Poly E, Lescuyer A, Carré N, Benhamed F, Goenaga D, Burnol AF.

Cell Signal. 2015 Apr;27(4):798-806. doi: 10.1016/j.cellsig.2015.01.003. Epub 2015 Jan 8.

PMID:
25578860
9.

[The transcription factor ChREBP: a key modulator of insulin sensitivity?].

Benhamed F, Poupeau A, Postic C.

Med Sci (Paris). 2013 Aug-Sep;29(8-9):765-71. doi: 10.1051/medsci/2013298016. Epub 2013 Sep 5. Review. French.

10.

The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.

Benhamed F, Denechaud PD, Lemoine M, Robichon C, Moldes M, Bertrand-Michel J, Ratziu V, Serfaty L, Housset C, Capeau J, Girard J, Guillou H, Postic C.

J Clin Invest. 2012 Jun;122(6):2176-94. doi: 10.1172/JCI41636. Epub 2012 May 1.

11.

Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice.

Bricambert J, Miranda J, Benhamed F, Girard J, Postic C, Dentin R.

J Clin Invest. 2010 Dec;120(12):4316-31. doi: 10.1172/JCI41624. Epub 2010 Nov 15.

12.

[The regulation of gene expression by glucose].

Girard J, Dentin R, Benhamed F, Denechaud PD, Postic C.

J Soc Biol. 2007;201(2):159-64. French.

PMID:
17978749
13.

Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.

Dentin R, Benhamed F, Hainault I, Fauveau V, Foufelle F, Dyck JR, Girard J, Postic C.

Diabetes. 2006 Aug;55(8):2159-70.

14.

Hepatic gene regulation by glucose and polyunsaturated fatty acids: a role for ChREBP.

Dentin R, Denechaud PD, Benhamed F, Girard J, Postic C.

J Nutr. 2006 May;136(5):1145-9. Review.

PMID:
16614395
15.

Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage.

Knauf C, Cani PD, Perrin C, Iglesias MA, Maury JF, Bernard E, Benhamed F, Grémeaux T, Drucker DJ, Kahn CR, Girard J, Tanti JF, Delzenne NM, Postic C, Burcelin R.

J Clin Invest. 2005 Dec;115(12):3554-63.

16.

Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation.

Dentin R, Benhamed F, Pégorier JP, Foufelle F, Viollet B, Vaulont S, Girard J, Postic C.

J Clin Invest. 2005 Oct;115(10):2843-54. Epub 2005 Sep 22.

17.

Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression.

Dentin R, Pégorier JP, Benhamed F, Foufelle F, Ferré P, Fauveau V, Magnuson MA, Girard J, Postic C.

J Biol Chem. 2004 May 7;279(19):20314-26. Epub 2004 Feb 25.

Supplemental Content

Loading ...
Support Center